Editas Medicine Inc.

(EDIT) Trade

By |

Profile

Editas Medicine Inc is a US-based genome editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company operates its business in a single segment of Developing and commercializing genome editing technology.

Contact Information

Website: www.editasmedicine.com
Email: info@editasmed.com
Main Phone: +1 617 401-9000
Address: 11 Hurley Street
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02141

Issuer Information

Exchange: NGS
CEO: Katrine S. Bosley
Employees: 112
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Editas Medicine Inc is a US-based genome editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company operates its business in a single segment of Developing and commercializing genome editing technology.

Contact Information

Website: www.editasmedicine.com
Email: info@editasmed.com
Main Phone: +1 617 401-9000
Address: 11 Hurley Street
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02141

Issuer Information

Exchange: NGS
CEO: Katrine S. Bosley
Employees: 112
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 26.21 $ -0.05 (-0.19%)
Last Price 26.21 Change $ -0.05 Change % -0.19 Tick N/A
Bid 26.01 Bid Size 200.00 Ask 27.13 Ask Size 300.00
Open 26.16 High 26.61 Low 25.85 Prev Close 26.26
Last Trade Volume 408,721 52 Wk Hi 45.02 52 Wk Low 17.80
Market Cap 1.3 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 47,810,190.00 EPS (TTM) -2.66 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 26 70
Number of Buys 10 19
Number of Sells 16 51
Net Activity -14999 -135777
Last 10 Buys Shares
James C. Mullen 1,000
Gerald Frank Cox 1,000
Boris Nikolic 1,000
Flynn E James 1,000
Last 10 Sell Shares
Andrew A. F. Hack 1,000
Katrine S. Bosley 1,000
Katrine S. Bosley 1,000
Katrine S. Bosley 1,000
Andrew A. F. Hack 1,000
Andrew A. F. Hack 1,000
Katrine S. Bosley 1,000
Charles Albright 1,000
Katrine S. Bosley 1,000
Katrine S. Bosley 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 55 55 55 55
Low Target Price Estimate 36 36 36 36
Mean Target Price Estimate 44.2 44.2 44.2 44.2
Standard Deviation 7.33 7.33 7.33 7.33
Date of Most Recent Estimate 05/15/18 05/15/18 05/15/18 05/15/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.86 1.86 1.86 1.86